Shionogi Inc. Announces FDA Approval of Cuvposa for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions(3)
添加时间:2010-08-02 原文发表:2010-08-02 人气:73
本文章共3231字，分3页，当前第3页，快速翻页：
Source: Shionogi Inc.
CONTACT: Shionogi Inc., Joseph T. Schepers, +1-678-341-1401,
ir@shionogipharma.com; or HealthStar PR, Dave Schemelia, +1-609-468-9325,
dschemelia@healthstarpr.com